• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者和肿瘤特征对接受立体定向体部放射治疗(SBRT)的早期周围型肺癌(Tis~T2bN0M0)呼吸运动的影响。

Effect of patient and tumor characteristics on respiratory motion in early-stage peripheral lung cancer (Tis ~ T2bN0M0) treated with stereotactic body radiation therapy (SBRT).

作者信息

Mitsuhashi Norio, Tominaga Daichi, Ikeda Hajime, Shiina Fumiya, Fukaya Keiko, Nemoto Yoshitaka

机构信息

Radiation Therapy Center, Hitachinaka General Hospital, Hitachinaka, Japan.

Department of Radiotherapy, Hitachinaka General Hospital, Hitachinaka, Japan.

出版信息

Rep Pract Oncol Radiother. 2024 Oct 3;29(4):468-477. doi: 10.5603/rpor.101531. eCollection 2024.

DOI:10.5603/rpor.101531
PMID:39895962
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11785381/
Abstract

BACKGROUND

Recent advances in stereotactic body radiation therapy (SBRT) technology for early-stage peripheral lung cancer have been remarkable and are becoming a viable alternative to surgery. However, the most important problem in performing SBRT correctly is minimizing the respiratory motion of the tumor.

MATERIALS AND METHODS

Thirty-eight patients treated with SBRT were evaluated to clarify factors affecting respiratory motion of early-stage peripheral lung cancer in the management of restrictive breathing technique (abdominal compression) to reduce respiratory tumor motion in SBRT. We investigated age, gender, body mass index (BMI), Brinkman index (BI), forced expiratory volume in 1 second (FEV 1.0), and type of ventilatory impairment as patient factors, and T-factor, stage, tumor-bearing lung lobe, and tumor pathology as tumor factors. Respiratory motion was assessed by volume differences between clinical target volume (CTV) and internal target volume (ITV). The degree of tumor motion due to respiration was compared using the formula of (ITV-CTV)/CTV as an index.

RESULTS

In the results, univariate analyses showed that only age was a significant predictor of respiratory tumor motion (p = 0.048). In multi-variate analyses, only T factor was an independent significant predictor of respiratory tumor motion (p = 0.045), while there was a significant trend for age (p = 0.061), and tumor location (p = 0.067).

CONCLUSIONS

In late elderly patients or T1a tumor, respiratory motion in early-stage peripheral lung cancer was significantly large. However, it is not predictable by patient and tumor characteristics. Therefore, respiratory motion of the tumor should be measured in all patients in some way.

摘要

背景

立体定向体部放射治疗(SBRT)技术在早期周围型肺癌治疗方面取得了显著进展,正成为一种可行的手术替代方案。然而,正确实施SBRT最重要的问题是将肿瘤的呼吸运动降至最低。

材料与方法

对38例接受SBRT治疗的患者进行评估,以明确在限制性呼吸技术(腹部压迫)管理中影响早期周围型肺癌呼吸运动的因素,从而在SBRT中减少呼吸性肿瘤运动。我们调查了年龄、性别、体重指数(BMI)、 Brinkman指数(BI)、一秒用力呼气容积(FEV1.0)以及通气障碍类型作为患者因素,还调查了T因子、分期、肿瘤所在肺叶和肿瘤病理作为肿瘤因素。通过临床靶体积(CTV)与内靶体积(ITV)之间的体积差异评估呼吸运动。使用(ITV - CTV)/CTV公式作为指标比较因呼吸引起的肿瘤运动程度。

结果

结果显示,单因素分析表明只有年龄是呼吸性肿瘤运动的显著预测因素(p = 0.048)。多因素分析中,只有T因子是呼吸性肿瘤运动的独立显著预测因素(p = 0.045),而年龄(p = 0.061)和肿瘤位置(p = 0.067)有显著趋势。

结论

在老年晚期患者或T1a期肿瘤中,早期周围型肺癌的呼吸运动明显较大。然而,无法通过患者和肿瘤特征预测。因此,应以某种方式对所有患者测量肿瘤的呼吸运动。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fbc/11785381/9d091a8dc28f/rpor-29-4-468f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fbc/11785381/b301ec1e040e/rpor-29-4-468f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fbc/11785381/9d091a8dc28f/rpor-29-4-468f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fbc/11785381/b301ec1e040e/rpor-29-4-468f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fbc/11785381/9d091a8dc28f/rpor-29-4-468f2.jpg

相似文献

1
Effect of patient and tumor characteristics on respiratory motion in early-stage peripheral lung cancer (Tis ~ T2bN0M0) treated with stereotactic body radiation therapy (SBRT).患者和肿瘤特征对接受立体定向体部放射治疗(SBRT)的早期周围型肺癌(Tis~T2bN0M0)呼吸运动的影响。
Rep Pract Oncol Radiother. 2024 Oct 3;29(4):468-477. doi: 10.5603/rpor.101531. eCollection 2024.
2
Quantification of incidental dose to potential clinical target volume (CTV) under different stereotactic body radiation therapy (SBRT) techniques for non-small cell lung cancer - tumor motion and using internal target volume (ITV) could improve dose distribution in CTV.非小细胞肺癌不同立体定向体部放射治疗(SBRT)技术下潜在临床靶区(CTV)的附带剂量量化——肿瘤运动及使用内部靶区(ITV)可改善CTV的剂量分布。
Radiother Oncol. 2007 Nov;85(2):267-76. doi: 10.1016/j.radonc.2007.09.004. Epub 2007 Oct 1.
3
Quantitative evaluation of accumulated and planned dose deviations in patients undergoing gated and non-gated lung stereotactic body radiation therapy patients: a retrospective analysis.门控和非门控肺部立体定向体部放射治疗患者累积和计划剂量偏差的定量评估:一项回顾性分析
Transl Lung Cancer Res. 2024 Dec 31;13(12):3616-3628. doi: 10.21037/tlcr-24-992. Epub 2024 Dec 27.
4
Evaluation of the target dose coverage of stereotactic body radiotherapy for lung cancer using helical tomotherapy: A dynamic phantom study.使用螺旋断层放疗评估立体定向体部放疗对肺癌的靶区剂量覆盖:一项动态体模研究。
Rep Pract Oncol Radiother. 2020 Mar-Apr;25(2):200-205. doi: 10.1016/j.rpor.2020.01.001. Epub 2020 Jan 14.
5
Dosimetric Implications of Number of Breathing Phases Used in the Definition of Internal Target Volume [ITV] in the Treatment of Non-Small Cell Lung Cancers Using Stereotactic Body Radiation Therapy (SBRT).立体定向体部放射治疗(SBRT)用于治疗非小细胞肺癌时,内部靶区体积[ITV]定义中使用的呼吸相数量的剂量学意义。
Ann Lung Cancer. 2019;3(1):75-83. Epub 2019 Oct 5.
6
Clinical outcomes following advanced respiratory motion management (respiratory gating or dynamic tumor tracking) with stereotactic body radiation therapy for stage I non-small-cell lung cancer.采用立体定向体部放射治疗联合先进呼吸运动管理(呼吸门控或动态肿瘤追踪)治疗I期非小细胞肺癌后的临床结果
Lung Cancer (Auckl). 2018 Nov 5;9:103-110. doi: 10.2147/LCTT.S175168. eCollection 2018.
7
Reduction of margin to compensate the respiratory tumor motion by the analysis of dosimetric internal target volume in lung SBRT with nonuniform volume prescription method.采用非均匀剂量处方方法对肺部 SBRT 中的剂量学内靶区进行分析,以减少边缘来补偿呼吸肿瘤运动。
Med Phys. 2021 Jun;48(6):3200-3207. doi: 10.1002/mp.14871. Epub 2021 Apr 24.
8
Selection of motion management in liver stereotactic body radiotherapy and its impact on treatment time.肝脏立体定向体部放疗中运动管理的选择及其对治疗时间的影响。
Phys Imaging Radiat Oncol. 2023 Jan 4;25:100407. doi: 10.1016/j.phro.2022.12.004. eCollection 2023 Jan.
9
Quantification and minimization of uncertainties of internal target volume for stereotactic body radiation therapy of lung cancer.肺癌立体定向体部放射治疗中内部靶区不确定性的量化和最小化。
Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):438-43. doi: 10.1016/j.ijrobp.2012.04.032. Epub 2012 Jun 9.
10
Predictors of pneumonitis-free survival following lung stereotactic body radiation therapy.肺立体定向体部放疗后无肺炎生存的预测因素。
Transl Lung Cancer Res. 2019 Feb;8(1):15-23. doi: 10.21037/tlcr.2018.10.11.

引用本文的文献

1
Salvage lung SBRT may be a curative option after lobectomy.挽救性肺部立体定向体部放疗可能是肺叶切除术后的一种治愈性选择。
Rep Pract Oncol Radiother. 2025 Mar 21;30(1):27-33. doi: 10.5603/rpor.104385. eCollection 2025.

本文引用的文献

1
Stereotactic body radiotherapy versus surgery for early-stage non-small cell lung cancer: an updated meta-analysis involving 29,511 patients included in comparative studies.立体定向体部放疗与手术治疗早期非小细胞肺癌:纳入比较研究的 29511 例患者的更新荟萃分析。
J Bras Pneumol. 2022 Apr 29;48(3):e20210390. doi: 10.36416/1806-3756/e20210390. eCollection 2022.
2
Effect of abdominal compression on target movement and extension of the external boundary of peripheral lung tumours treated with stereotactic radiotherapy based on four-dimensional computed tomography.基于四维 CT 的立体定向放疗治疗外周肺部肿瘤时,腹部压迫对靶区运动和外部边界扩展的影响。
Radiat Oncol. 2021 Sep 7;16(1):173. doi: 10.1186/s13014-021-01889-0.
3
GOECP/SEOR radiotherapy guidelines for small-cell lung cancer.
GOECP/SEOR小细胞肺癌放射治疗指南。
World J Clin Oncol. 2021 Mar 24;12(3):115-143. doi: 10.5306/wjco.v12.i3.115.
4
Comparison of Long-term Survival of Patients With Early-Stage Non-Small Cell Lung Cancer After Surgery vs Stereotactic Body Radiotherapy.比较手术与立体定向体部放疗治疗早期非小细胞肺癌患者的长期生存情况。
JAMA Netw Open. 2019 Nov 1;2(11):e1915724. doi: 10.1001/jamanetworkopen.2019.15724.
5
Developments in Stereotactic Body Radiotherapy.立体定向体部放射治疗的进展
Cancers (Basel). 2018 Dec 7;10(12):497. doi: 10.3390/cancers10120497.
6
Stereotactic body radiotherapy (SBRT) for Stage I lung cancer.I期肺癌的立体定向体部放射治疗(SBRT)。
Jpn J Clin Oncol. 2018 May 1;48(5):405-409. doi: 10.1093/jjco/hyy034.
7
Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review.手术与立体定向体部放射治疗Ⅰ期非小细胞肺癌:全面综述。
Cancer. 2018 Feb 15;124(4):667-678. doi: 10.1002/cncr.31196. Epub 2017 Dec 19.
8
Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline.立体定向体部放疗治疗早期非小细胞肺癌:美国临床肿瘤学会对美国放射肿瘤学会循证指南的认可。
J Clin Oncol. 2018 Mar 1;36(7):710-719. doi: 10.1200/JCO.2017.74.9671. Epub 2017 Nov 6.
9
Motion management strategies and technical issues associated with stereotactic body radiotherapy of thoracic and upper abdominal tumors: A review from NRG oncology.立体定向体部放疗治疗胸腹部肿瘤的运动管理策略和技术问题:NRG 肿瘤学的综述。
Med Phys. 2017 Jun;44(6):2595-2612. doi: 10.1002/mp.12227. Epub 2017 Apr 20.
10
Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403.立体定向体部放疗治疗可手术和不可手术 T1N0M0 期非小细胞肺癌的前瞻性研究:日本临床肿瘤学组研究 JCOG0403。
Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):989-96. doi: 10.1016/j.ijrobp.2015.07.2278. Epub 2015 Nov 11.